unknown
Stage
1
Investors
About
Verge Genomics uses machine learning applied to human genomics and biological data to discover and develop small-molecule therapeutics for neurodegenerative diseases such as ALS.
Explore Verge Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.